1. Market Research
  2. > Healthcare
  3. > Pathology Market Trends
  4. > Women's Health Diagnostic Markets

Women's Health Diagnostic Markets

  • October 2014
  • -
  • Kalorama Information
  • -
  • 237 pages

The women's health arena, both therapeutics and diagnostics, has grown considerably as a specialty medical field. Once limited to obstetrics and gynecology, it now includes other fields, such as urology, maternal-fetal medicine, as well as autoimmune disease and cystic fibrosis. At many clinics and practices focused on the health of women, a range of specialties are offered, which often results in a need for specific types of women's health-related testing. Generally, and from a perspective on women's health, diagnostics are playing an ever increasing role.

Worldwide, women are living longer than men. There is a need to improve the understanding of the differences, in terms of health, between the sexes and to translate that knowledge into improved medical diagnostics, practice and therapies.

Kalorama Information's Women's Health Diagnostic Markets analyzes the current and potential world markets for key diagnostic tests targeted at women's health. This report generally forecasts future market growth for these tests to 2018. Market segments covered include the US, Europe, China, Brazil, Japan and rest of world markets.

The report presents market developments in women's health diagnostics, including in-depth analysis of the following testing fields:

Pregnancy and Ovulation Testing
Bone Density Testing
Prenatal Screening
Pap Smears
HPV Testing
Ovarian Cancer Testing
Urinary Tract Infections
Neonatal Jaundice
Autoimmune Disease
Cystic Fibrosis

Over the next few decades, comprehensive genomics-based health care should be the norm in the US and much of Europe. In the next decade, genetic tests will routinely predict individual susceptibility to disease. Diagnoses of many conditions will be much more thorough and specific than now. The report gives insight into understanding the molecular basis of disease.

Women's Health Diagnostic Markets also reviews the nature and direction of research and trends, and gives insight into some issues facing the industry. The report profiles several key companies, including large companies that have made names for themselves in the field, as well as smaller firms with market niches. These companies are involved in developing and marketing over the counter (OTC), point of care (POC) in vitro diagnostic (IVD) tests and screening systems.

Some of the companies profiled include:

GE Healthcare
GenMark Diagnostics
Immco Diagnostics
Nova Biomedical
Philips Healthcare
Siemens Healthcare
Somagen Diagnostics

Market forecasts are based on an examination of current market conditions and on investigations into the development of new products by key companies. The market data are generated into multiple year forecasts for different product segments covered in the report. The information presented in this report is the result of data gathered from company product literature and other corporate brochures and documents, as well as information found in the scientific and trade press. In addition, interviews were conducted with company executives and researchers.

Table Of Contents

Women's Health Diagnostic Markets
1.0 Executive Summary
1.1 Methodology
2.0 Introduction
2.1 Female Health: Room for Improvement
2.2 Perspective on Women's Health
2.3 The Way Women and Men Develop Disease Is Different
2.3.1 Pain
2.3.2 The Heart
2.3.3 The Brain
2.3.4 Emotions
2.3.5 Bone Structure
2.3.6 Alcohol
2.3.7 Drug Side Effects
2.3.8 Smoking
2.3.9 Fertility
2.3.10 STIs/HIV
2.3.11 Autoimmune Disease
2.3.12 Cancer
2.3.13 Musculoskeletal Health
2.3.14 Birth Defects
2.3.15 Urinary Tract Infections
2.4 Key Leading Causes of Death in Females
2.5 Demographics
2.6 What Claims Women's Lives
2.7 Key Trends and Issues in Women's Diagnostics
2.7.1 OVA1
2.7.2 CA-125
2.7.3 HER2
2.8 Understanding the Molecular Basis of Disease
2.8.1 Managing Cancer Disease and Costs through Reimbursement
2.8.2 Ultrasound and Mammography Use Grows
3.0 Market Developments in Women's Health Diagnostics
3.1 Quest and Hologic Team Up
3.2 Quest Genetic Testing for Breast Cancer Risk
3.3 Sequenom, Quest Collaborate on Noninvasive Prenatal Testing
3.4 Partnering to Make Personalized Infertility Treatment Possible
3.5 Co-Marketing of Full-Length HLA Gene Sequencing Products
3.6 Acquisition Strengthens Theranostics Development
3.7 Trinity Biotech Acquisition
3.8 Noninvasive Prenatal Test Significantly Reduces False Positive Rate
3.9 Proteome Sciences, Fisher Scientific Sign Agreement on Cancer Tests
3.10 Agreement on Fetal and Maternal Monitoring Software
3.11 Distribution Agreement for OTC Women's Health Diagnostics
3.12 Women's Health Cancer Diagnostics Company Raises $11.3 Million
3.13 Crowd Funding for At-Home Breast Exam Device
3.14 $13M Series A Round for Ultrasound Fibroid Device
3.15 FDA Clears Femur Fracture Test
3.16 FDA 510(k) Clearance for Female Incontinence Device
3.17 GE PMA for extended labeling for Senographe Mammography
3.18 FDA Clears MicroDose Mammography
3.19 FDA ABUS Approval
3.20 FDA Approval for Imaging Software System for Ultrasound
3.21 EU Nod for Breast Tissue Screening System
3.22 Cervical Cancer Screening Test Concerns
3.23 New Smartphone App Detects Newborn Jaundice in Minutes
4.0 Pregnancy and Ovulation
Key Trend
4.1 Perspective on Testing
4.1.1 Digital Testing
4.1.2 Testing for Placental Growth Factor and Pre-eclampsia
4.1.3 Lab Developed Tests
4.2 OTC Pregnancy Self-Test Market
4.3 Lab-Based Fertility Testing Market
4.4 Lab-Based Torch Testing Market
4.5 Abbott Diagnostics
4.6 Alere Inc.
4.7 biomerieux SA
4.8 Church and Dwight Co. Inc
4.9 Dialab GMBH
4.10 Prestige Diagnostics
4.11 Roche Diagnostics
4.12 Siemens Healthcare Diagnostics
5.0 Bone Density Testing
Key Trend
5.1 Alarming Rise of Osteoporosis
5.2 Propelling the Need for Detection
5.3 DEXA and Competing Technologies
5.4 Bone Densitometer Market
5.5 GE Healthcare
5.6 Hologic
5.7 Osteometer MediTech
6.0 Prenatal Screening
Key Trend
6.1 Invasive Testing
6.2 Noninvasive Testing
6.3 The Impact of Prenatal Genetic Testing
6.4 DNA Assay Market
6.5 Prenatal Carrier and Fetus Screening Market
6.6 PerkinElmer
6.7 Quest Diagnostics
6.8 ScreenCell
6.9 Sequenom
6.10 Laboratory Corporation of America
7.0 Ultrasound
Key Trend
7.1 History and Perspective
7.2 Nuchal Translucency
7.3 Speckle Reduction
7.4 Volumetric Imaging
7.5 Follicular Tracking
7.6 Obstetrics and Gynecology
7.7 Breast Imaging
7.8 Ob/Gyn Market
7.9 Breast Imaging Market
7.10 Analogic
7.11 Philips Healthcare
7.12 Siemens Healthcare
7.13 GE Healthcare
7.14 Hitachi Aloka Medical Ltd.
7.15 Supersonic Imagine
8.0 Mammography
Key Trend
8.1 Perspective
8.1.1 Economics of Routine Screening
8.2 Transitioning to Digital
8.3 Computer-Aided Detection
8.3.1 A Second Opinion
8.3.2 Analyzing Tumor Characteristics
8.4 Mammography Systems Market
8.5 CAD Market
8.6 Carestream Health
8.7 FujiFilm Medical Systems USA
8.8 GE Healthcare
8.9 Hologic
8.10 iCAD Inc
8.11 Parascript LLC
8.12 R2 Technology
9.0 Pap Smears
Key Trend
9.1 Testing for Cervical Cancer
9.1.1 Types of Screening
9.2 Cervical Cancer Vaccines
9.3 A Market Need
9.4 IVD Market
9.5 BD
9.6 BioReference Laboratories
9.7 BioSciCon
9.8 Hologic
9.9 Innogenetics NV
10.0 Colposcopy
Key Trend
10.1 Colposcopy Biopsy
10.2 Abnormal Pap Smear Results
10.3 Routine Use But Mature Market
10.3.1 Primary and Secondary Screening
10.4 Colposcopy Systems Market
10.5 CooperSurgical
10.6 DySIS Medical
10.7 Guided Therapeutics
10.8 Leisegang
10.9 NeoDiagnostix
11.0 HPV Testing
Key Trend
11.1 HPV Infection
11.1.1 Infection in Females
11.1.2 High Risk Types
11.1.3 HPV Major Cause of Cervical Cancer
11.2 HPV Test
11.3 Vaccine Issues
11.4 Strong Market Expected
11.4.1 IVD Market
11.5 Abbott Molecular
11.6 Hologic
11.7 Qiagen Benelux BV
11.8 Roche Diagnostics
12.0 Ovarian Cancer
Key Trend
12.1 Types of Ovarian Cancer
12.2 Pelvic Examinations
12.3 Tumor Markers, AFP, HE4
12.4 CA-125 Antigen
12.5 CA-125 Market
12.6 Avant Diagnostics Inc.
12.7 Biosystems International
12.8 Fujirebio Diagnostics
12.9 Myriad Genetics Inc.
13.0 Urinary Tract Infections
Key Trend
13.1 Leading Cause of Morbidity and Death
13.1.1 Impact
13.1.2 Impact on Women
13.1.3 E. coli the Key Culprit
13.2 UTI Molecular Testing Market
13.3 i-Health Inc.
13.4 Liofilchem
13.5 Rheonix
13.6 Somagen Diagnostics
14.0 Neonatal Jaundice
Key Trend
14.1 Issues Involving Bilirubin
14.2 Two Factors in Neonates
14.3 Risk Factors
14.4 Smart Phone App
14.5 Bilirubin Testing Market
14.6 Instrumentation Laboratory
14.7 Nova Biomedical
14.8 Siemens Healthcare Diagnostics
14.9 Wako Diagnostics
14.10 Roche Diagnostics
15.0 Autoimmune Disease
Key Trend
15.1 Types of Autoimmune Disease
15.2 Genetic Factors
15.3 Impact on Females
15.4 Female Lab-Based Immunoassay Autoimmune Testing Market
15.5 Aesku.Diagnostics
15.6 AXA Diagnostics SRL
15.7 Bio-Rad Laboratories
15.8 Euroimmun AG
15.9 Immco Diagnostics
15.10 Kronus
15.11 Phadia
15.12 XDx
16.0 Cystic Fibrosis
Key Trend
16.1 Affecting the Entire Body
16.2 Reduced Life Expectancy
16.3 Genetics
16.4 Chronic Infections
16.5 Females Worse Than Males
16.6 Genetic Testing Market
16.7 AutoGenomics
16.8 GenMark Diagnostics
16.9 Illumina
16.10 Luminex
16.11 ScheBo ' Biotech AG
16.12 Sequenom

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
2017-2021 World Sexually-Transmitted Disease (STD) Diagnostics Market: Chancroid, Chlamydia, Gonorrhea, Herpes, HPV, Syphilis--Supplier Shares, Sales Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation

2017-2021 World Sexually-Transmitted Disease (STD) Diagnostics Market: Chancroid, Chlamydia, Gonorrhea, Herpes, HPV, Syphilis--Supplier Shares, Sales Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation

  • $ 9600
  • Industry report
  • January 2017
  • by Venture Planning Group

About this Report This report presents a detailed analysis of the STD market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan.  Current scientific views on epidemiology and etiology are ...

2017-2021 Sexually-Transmitted Diseases (STD) Diagnostic Testing Market

2017-2021 Sexually-Transmitted Diseases (STD) Diagnostic Testing Market

  • $ 6200
  • Industry report
  • February 2017
  • by Venture Planning Group

Complete report $9,600.  DataPack (test volumes, sales forecasts, supplier shares) $6,200. This new 350-page report from VPGMarketResearch.com contains 90 tables and provides analysis of the global s ...

2017-2021 World Sexually-Transmitted Diseases (STD) Market: Global Opportunities and Growth Strategies for Suppliers

2017-2021 World Sexually-Transmitted Diseases (STD) Market: Global Opportunities and Growth Strategies for Suppliers

  • $ 6200
  • Industry report
  • February 2017
  • by Venture Planning Group

Complete report $9,600.  DataPack (test volumes, sales forecasts, supplier shares) $6,200. This new 350-page report from VPGMarketResearch.com contains 90 tables and provides analysis of the global s ...

Download Unlimited Documents from Trusted Public Sources

Tuberculosis Statistics

  • February 2017
    200 pages
  • Infectious Dise...  


  • United States  

    North America  


View report >

Blood Supply Industry in Namibia and Africa

  • February 2017
    209 pages
  • Health Care Pro...  

    Blood Supply  

    HIV AIDS  

  • Namibia  



View report >

Sexually Transmitted Disease Statistics in India

  • February 2017
    10 pages
  • Sexually Transm...  

    Infectious Dise...  

  • India  

View report >


Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.